Literature DB >> 2138475

The biological significance of soluble interleukin-2 receptors in solid tumors.

P Lissoni1, S Barni, F Rovelli, S Viviani, G J Maestroni, A Conti, G Tancini.   

Abstract

In an attempt to further understand the biological significance of soluble IL-2 receptors (sIL-2R) in solid tumors, we have evaluated 160 cancer patients (breast: 40; lung: 66; colon: 18; stomach: 22; uterine cervix: 14) and 58 healthy subjects, as controls. Serum mean levels of sIL-2R, measured with an enzyme immunoassay, were significantly higher in cancer patients than in controls. Metastatic cancer patients showed significantly higher values than the non-metastatic ones; this difference was significant in all tumor histotypes, except small cell lung carcinoma. Moreover, in 15 patients in whom sIL-2R were evaluated either before or after radical surgery, a significant surgery-induced increase in sIL-R mean values was seen. Finally, the chemotherapy-induced rise in sIL-2R appeared to be associated with a lack of clinical response. These results seem to suggest that sIL-2R may be a marker of host biological response in patients with solid tumors, the significance of which needs further investigation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138475     DOI: 10.1016/0277-5379(90)90253-p

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  12 in total

1.  Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice.

Authors:  S Visonneau; A Cesano; M H Torosian; E J Miller; D Santoli
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

2.  Neopterin serum levels in pancreatic adenocarcinoma.

Authors:  G Manes; O A Spada; P G Rabitti; B Feola; S Misso; A Minerva; G Uomo
Journal:  Int J Pancreatol       Date:  1999-02

3.  The serum levels of soluble interleukin-2 receptor alpha and lactate dehydrogenase but not of B2-microglobulin correlate with selected clinico-pathological prognostic factors and response to therapy in childhood soft tissue sarcomas.

Authors:  Ewa Bien; Malgorzata Rapala; Malgorzata Krawczyk; Anna Balcerska
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-20       Impact factor: 4.553

4.  Serum soluble interleukin 2 (IL-2) receptor (sIL-2R) in differentiated thyroid carcinoma.

Authors:  S Mariotti; G Barbesino; P Caturegli; M Marinò; L Manetti; L Fugazzola; F Pacini; A Pinchera
Journal:  J Endocrinol Invest       Date:  1994-12       Impact factor: 4.256

5.  Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer.

Authors:  B Nakata; K H Chung; Y Kato; Y Yamashita; A Inui; Y Arimoto; K Maeda; N Onoda; T Sawada; M Sowa
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

6.  Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer.

Authors:  Z-Y Chen; K Raghav; C H Lieu; Z-Q Jiang; C Eng; J-N Vauthey; G J Chang; W Qiao; J Morris; D Hong; P Hoff; H Tran; D G Menter; J Heymach; M Overman; S Kopetz
Journal:  Br J Cancer       Date:  2015-03-17       Impact factor: 7.640

7.  Stromal IL2 is related to the neutrophil/lymphocyte ratio in epithelial ovarian cancer.

Authors:  T D Santos; M P Jammal; T P Silveira; E F C Murta; R S Nomelini
Journal:  Pathologica       Date:  2019-06

Review 8.  On the role of sIL-2R measurements in rheumatoid arthritis and cancers.

Authors:  Anna Maria Witkowska
Journal:  Mediators Inflamm       Date:  2005-08-14       Impact factor: 4.711

9.  Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response.

Authors:  A Martens; R A Janssen; D T Sleijfer; A A Heijn; N H Mulder; T H The; L de Leij
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

10.  Biological significance of soluble IL-2 receptor.

Authors:  C Caruso; G Candore; D Cigna; A T Colucci; M A Modica
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.